Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma

Jennifer M. Wiggins, Qiao Zhang, Yian Zhang, Fatemeh Vand-Rajabpour, Douglas Hanniford, Linchen He, Yuting Lu, Jessica M. Kenney, Keimya D. Sadeghi, Diana Argibay, Irene Orlow, Klaus J. Busam, Cecilia Lezcano, Tim K. Lee, Li Luo, Ivan P. Gorlov, Christopher Amos, Marc S. Ernstoff, Venkatraman E. Seshan, Anne E. Cust, James Wilmott, Richard A. Scolyer, Graham J. Mann, Allison Reiner, Caroline E. Kostrzewa, Eduardo Nagore, Pauline Funchain, Jennifer Ko, Sharon N. Edmiston, Kathleen Conway, Paul B. Googe, David W. Ollila, Jeffrey E. Lee, Judy R. Rees, Cheryl L. Thompson, Meg Gerstenblith, Marcus Bosenberg, Bonnie E. Gould Rothberg, Iman Osman, Yvonne Saenger, Adam Z. Reynolds, Tawny Boyce, Sheri Holmen, Shaofeng Yan, Elise Brunsgaard, Paul Bogner, Pei Fen Kuan, Nancy E. Thomas, Colin B. Begg, Ronglai Shen, Marianne Berwick, Yongzhao Shao, David Polsky, Eva Hernando

Open source

DOI
10.1158/1078-0432.ccr-24-3785
Published
2025-10-20
Container
Clinical Cancer Research
Publisher
American Association for Cancer Research (AACR)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-24-3785,
  title = {Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma},
  author = {Jennifer M. Wiggins and Qiao Zhang and Yian Zhang and Fatemeh Vand-Rajabpour and Douglas Hanniford and Linchen He and Yuting Lu and Jessica M. Kenney and Keimya D. Sadeghi and Diana Argibay and Irene Orlow and Klaus J. Busam and Cecilia Lezcano and Tim K. Lee and Li Luo and Ivan P. Gorlov and Christopher Amos and Marc S. Ernstoff and Venkatraman E. Seshan and Anne E. Cust and James Wilmott and Richard A. Scolyer and Graham J. Mann and Allison Reiner and Caroline E. Kostrzewa and Eduardo Nagore and Pauline Funchain and Jennifer Ko and Sharon N. Edmiston and Kathleen Conway and Paul B. Googe and David W. Ollila and Jeffrey E. Lee and Judy R. Rees and Cheryl L. Thompson and Meg Gerstenblith and Marcus Bosenberg and Bonnie E. Gould Rothberg and Iman Osman and Yvonne Saenger and Adam Z. Reynolds and Tawny Boyce and Sheri Holmen and Shaofeng Yan and Elise Brunsgaard and Paul Bogner and Pei Fen Kuan and Nancy E. Thomas and Colin B. Begg and Ronglai Shen and Marianne Berwick and Yongzhao Shao and David Polsky and Eva Hernando},
  year = {2025},
  journal = {Clinical Cancer Research},
  doi = {10.1158/1078-0432.ccr-24-3785},
  url = {https://doi.org/10.1158/1078-0432.ccr-24-3785}
}

RIS

TY  - JOUR
TI  - Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma
AU  - Jennifer M. Wiggins
AU  - Qiao Zhang
AU  - Yian Zhang
AU  - Fatemeh Vand-Rajabpour
AU  - Douglas Hanniford
AU  - Linchen He
AU  - Yuting Lu
AU  - Jessica M. Kenney
AU  - Keimya D. Sadeghi
AU  - Diana Argibay
AU  - Irene Orlow
AU  - Klaus J. Busam
AU  - Cecilia Lezcano
AU  - Tim K. Lee
AU  - Li Luo
AU  - Ivan P. Gorlov
AU  - Christopher Amos
AU  - Marc S. Ernstoff
AU  - Venkatraman E. Seshan
AU  - Anne E. Cust
AU  - James Wilmott
AU  - Richard A. Scolyer
AU  - Graham J. Mann
AU  - Allison Reiner
AU  - Caroline E. Kostrzewa
AU  - Eduardo Nagore
AU  - Pauline Funchain
AU  - Jennifer Ko
AU  - Sharon N. Edmiston
AU  - Kathleen Conway
AU  - Paul B. Googe
AU  - David W. Ollila
AU  - Jeffrey E. Lee
AU  - Judy R. Rees
AU  - Cheryl L. Thompson
AU  - Meg Gerstenblith
AU  - Marcus Bosenberg
AU  - Bonnie E. Gould Rothberg
AU  - Iman Osman
AU  - Yvonne Saenger
AU  - Adam Z. Reynolds
AU  - Tawny Boyce
AU  - Sheri Holmen
AU  - Shaofeng Yan
AU  - Elise Brunsgaard
AU  - Paul Bogner
AU  - Pei Fen Kuan
AU  - Nancy E. Thomas
AU  - Colin B. Begg
AU  - Ronglai Shen
AU  - Marianne Berwick
AU  - Yongzhao Shao
AU  - David Polsky
AU  - Eva Hernando
PY  - 2025
JO  - Clinical Cancer Research
DO  - 10.1158/1078-0432.ccr-24-3785
UR  - https://doi.org/10.1158/1078-0432.ccr-24-3785
ER  - 

APA

Wiggins, J. M., Zhang, Q., Zhang, Y., Vand-Rajabpour, F., Hanniford, D., He, L., Lu, Y., Kenney, J. M., Sadeghi, K. D., Argibay, D., Orlow, I., Busam, K. J., Lezcano, C., Lee, T. K., Luo, L., Gorlov, I. P., Amos, C., Ernstoff, M. S., Seshan, V. E., Cust, A. E., Wilmott, J., Scolyer, R. A., Mann, G. J., Reiner, A., Kostrzewa, C. E., Nagore, E., Funchain, P., Ko, J., Edmiston, S. N., Conway, K., Googe, P. B., Ollila, D. W., Lee, J. E., Rees, J. R., Thompson, C. L., Gerstenblith, M., Bosenberg, M., Rothberg, B. E. G., Osman, I., Saenger, Y., Reynolds, A. Z., Boyce, T., Holmen, S., Yan, S., Brunsgaard, E., Bogner, P., Kuan, P. F., Thomas, N. E., Begg, C. B., Shen, R., Berwick, M., Shao, Y., Polsky, D., & Hernando, E. (2025). Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-24-3785

Source records